PTC Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 154095000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2013-06-30) |
| Status | current |
| Entity | PTC Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:36:04.057982+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d541a059-20e0-4538-8476-af50cd411d40
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-14-058236Retrieved: 2026-08-19T10:36:04.057982+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001070081/cash-and-equivalents/2013-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d541a059-20e0-4538-8476-af50cd411d40
History
- supersedes {"amount": 154095269, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001104659-13-062994)